SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-107209
Filing Date
2023-10-05
Accepted
2023-10-05 16:32:01
Documents
14
Period of Report
2023-10-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327835d1_8k.htm   iXBRL 8-K 32690
2 EXHIBIT 99.1 tm2327835d1_ex99-1.htm EX-99.1 23350
6 GRAPHIC tm2327835d1_img001.jpg GRAPHIC 11929
  Complete submission text file 0001104659-23-107209.txt   253930

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20231005.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20231005_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20231005_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2327835d1_8k_htm.xml XML 3216
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 231311748
SIC: 2834 Pharmaceutical Preparations